The confidence in estimates for comparisons between tirzepatide and semaglutide was high to moderate, except for comparisons vs semaglutide 2.0 mg, where the confidence was low (ESM Table 12)
Based on current research, tirzepatide appears to offer the best balance of weight loss results and tolerability among the newer GLP-1 options
improves with slower dose escalation Vomiting, diarrhea, or constipation Bloating, heartburn, or stomach discomfort Reduced appetite and early fullness Fatigue or headache Less common side effects Injection-site reactions Fatigue or changes in taste Temporary mild hair thinning (limited evidence) Serious but rare risks Pancreatitis seek care immediately if you experience severe abdominal pain Gallbladder disease or gallstones Kidney complications, particularly from dehydration Thyroid C-cell tumor risk in patients with medullary thyroid cancer history or MEN2 Low blood sugar when combined with insulin or sulfonylureas Contact your provider immediately if you experience severe or persistent abdominal pain, constant vomiting, signs of dehydration, yellowing of the skin or eyes, or symptoms of low blood sugar
Maintenance Phase: 1 session per month to preserve and enhance your results
I didnt lose weight, but just the reduction in bloating was enough to make me fit comfortably into the incentive jeans hanging in my closet, so I was elated
We celebrate small wins along the way and create personalized programs tailored to produce successful chronic weight management
